Cite
HARVARD Citation
Leitch, H. et al. (2017). Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an MDS‐CAN analysis. British journal of haematology. pp. 83-97. [Online].